A citation-based method for searching scientific literature

Hao Yin, Chun-Qing Song, Sneha Suresh, Qiongqiong Wu, Stephen Walsh, Luke Hyunsik Rhym, Esther Mintzer, Mehmet Fatih Bolukbasi, Lihua Julie Zhu, Kevin Kauffman, Haiwei Mou, Alicia Oberholzer, Junmei Ding, Suet-Yan Kwan, Roman L Bogorad, Timofei Zatsepin, Victor Koteliansky, Scot A Wolfe, Wen Xue, Robert Langer, Daniel G Anderson. Nat Biotechnol 2017
Times Cited: 231



Rodolphe Barrangou, Christophe Fremaux, Hélène Deveau, Melissa Richards, Patrick Boyaval, Sylvain Moineau, Dennis A Romero, Philippe Horvath. Science 2007
Times Cited: 3166




List of shared articles



Times cited

Modulating CRISPR/Cas9 genome-editing activity by small molecules.
Siwei Chen, Deng Chen, Bin Liu, Hidde J Haisma. Drug Discov Today 2022
1

Strategies for Enhancing the Homology-Directed Repair Efficiency of CRISPR-Cas Systems.
Wenli Sun, Hui Liu, Wenhao Yin, Jie Qiao, Xueke Zhao, Yi Liu. CRISPR J 2022
0

Gene editing and its applications in biomedicine.
Guanglei Li, Xiangyang Li, Songkuan Zhuang, Liren Wang, Yifan Zhu, Yangcan Chen, Wen Sun, Zeguang Wu, Zhuo Zhou, Jia Chen,[...]. Sci China Life Sci 2022
2

Nanoparticles-Mediated CRISPR/Cas Gene Editing Delivery System.
Phei Er Saw, Guo-Hui Cui, Xiaoding Xu. ChemMedChem 2022
1

Pre-clinical non-viral vectors exploited for in vivo CRISPR/Cas9 gene editing: an overview.
Nadia Rouatbi, Tasneem McGlynn, Khuloud T Al-Jamal. Biomater Sci 2022
0

Rational designs of in vivo CRISPR-Cas delivery systems.
Cong-Fei Xu, Guo-Jun Chen, Ying-Li Luo, Yue Zhang, Gui Zhao, Zi-Dong Lu, Anna Czarna, Zhen Gu, Jun Wang. Adv Drug Deliv Rev 2021
52

Non-viral strategies for delivering genome editing enzymes.
Jie Li, Joachim Justad Røise, Maomao He, Riddha Das, Niren Murthy. Adv Drug Deliv Rev 2021
21

Approach for in vivo delivery of CRISPR/Cas system: a recent update and future prospect.
Yu-Fan Chuang, Andrew J Phipps, Fan-Li Lin, Valerie Hecht, Alex W Hewitt, Peng-Yuan Wang, Guei-Sheung Liu. Cell Mol Life Sci 2021
12

The evolution and history of gene editing technologies.
Shubhchintan Randhawa, Shatakshi Sengar. Prog Mol Biol Transl Sci 2021
0

Engineering Cas9 for human genome editing.
Ian M Slaymaker, Nicole M Gaudelli. Curr Opin Struct Biol 2021
4

Get ready for the CRISPR/Cas system: A beginner's guide to the engineering and design of guide RNAs.
Shufeng Ma, Jie Lv, Zinan Feng, Zhili Rong, Ying Lin. J Gene Med 2021
1

CRISPR-Cas Gene Perturbation and Editing in Human Induced Pluripotent Stem Cells.
Max van Essen, Joey Riepsaame, John Jacob. CRISPR J 2021
1

Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma.
Huimin Kong, Enguo Ju, Ke Yi, Weiguo Xu, Yeh-Hsing Lao, Du Cheng, Qi Zhang, Yu Tao, Mingqiang Li, Jianxun Ding. Adv Sci (Weinh) 2021
10

CRISPR/dCas9-Based Systems: Mechanisms and Applications in Plant Sciences.
Chou Khai Soong Karlson, Siti Nurfadhlina Mohd-Noor, Nadja Nolte, Boon Chin Tan. Plants (Basel) 2021
8

Gene editing with CRISPR-Cas12a guides possessing ribose-modified pseudoknot handles.
Eman A Ageely, Ramadevi Chilamkurthy, Sunit Jana, Leonora Abdullahu, Daniel O'Reilly, Philip J Jensik, Masad J Damha, Keith T Gagnon. Nat Commun 2021
2